- Home
- ROIV vs AGCO Comparison
ROIV vs AGCO Comparison
Compare ROIV & AGCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- AGCO
- Stock Information
- Founded
- ROIV 2014
- AGCO 1990
- Country
- ROIV United Kingdom
- AGCO United States
- Employees
- ROIV N/A
- AGCO N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- AGCO Industrial Machinery/Components
- Sector
- ROIV Health Care
- AGCO Industrials
- Exchange
- ROIV Nasdaq
- AGCO Nasdaq
- Market Cap
- ROIV 8.4B
- AGCO 6.8B
- IPO Year
- ROIV N/A
- AGCO 1992
- Fundamental
- Price
- ROIV $10.38
- AGCO $93.49
- Analyst Decision
- ROIV Strong Buy
- AGCO Buy
- Analyst Count
- ROIV 6
- AGCO 12
- Target Price
- ROIV $17.10
- AGCO $107.36
- AVG Volume (30 Days)
- ROIV 6.9M
- AGCO 978.4K
- Earning Date
- ROIV 02-10-2025
- AGCO 05-01-2025
- Dividend Yield
- ROIV N/A
- AGCO 1.22%
- EPS Growth
- ROIV N/A
- AGCO N/A
- EPS
- ROIV N/A
- AGCO N/A
- Revenue
- ROIV $122,585,000.00
- AGCO $11,661,900,000.00
- Revenue This Year
- ROIV N/A
- AGCO N/A
- Revenue Next Year
- ROIV N/A
- AGCO $6.25
- P/E Ratio
- ROIV N/A
- AGCO N/A
- Revenue Growth
- ROIV 140.04
- AGCO N/A
- 52 Week Low
- ROIV $9.96
- AGCO $84.35
- 52 Week High
- ROIV $13.06
- AGCO $125.76
- Technical
- Relative Strength Index (RSI)
- ROIV 42.16
- AGCO 45.20
- Support Level
- ROIV $10.63
- AGCO $91.91
- Resistance Level
- ROIV $11.42
- AGCO $99.72
- Average True Range (ATR)
- ROIV 0.36
- AGCO 3.11
- MACD
- ROIV -0.02
- AGCO 0.21
- Stochastic Oscillator
- ROIV 7.59
- AGCO 16.00
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About AGCO AGCO Corporation
Agco is a global manufacturer of agricultural equipment. The company has five core brands: Fendt, Massey Ferguson, Challenger, Valtra, and GSI. Unlike its competitors, Agco's product line extends beyond self-propelled equipment and implements to grain handling systems and livestock management solutions. Its products are available through a global dealer network, which includes about 3,100 dealer and distribution locations. Agco offers retail and wholesale financing to customers through its joint venture with Rabobank, a European food- and agriculture-focused bank.